KORU Medical Director Robert Cascella Receives 5,119-Share Award

What Happened

• Robert Cascella, a director of KORU Medical Systems, Inc. (KRMD), was awarded 5,119 shares on October 1, 2026. The award price is reported at $2.93 per share, with a total reported value of $14,999. This filing reports an acquisition via award/grant (transaction code A), which is commonly a form of compensation rather than an open‑market purchase.

Key Details

• Transaction date: 2026-10-01; Price per share: $2.93; Shares acquired: 5,119; Total value: $14,999.
• Shares owned after the transaction: Not specified in the provided summary of the Form 4.
• Filing timeliness: Reported on the same date as the transaction (filed 2026-10-01), indicating a timely filing.
• Footnotes/remarks: The filing includes a standard disclaimer that it is not an admission of beneficial ownership and notes a previously filed Power of Attorney.

Context

• This was an award/grant (not an open‑market buy or sale), typically part of director compensation. Such awards signal alignment with shareholders (adds equity to the insider’s holdings) but do not necessarily reflect a trading decision based on near‑term views of the stock.
• The reported value is modest (~$15k), so while it increases insider ownership, it’s a relatively small dollar amount compared with blockbuster grants or executive option exercises.